Huang, Qi-Fang
Zhang, Di
Luo, Yihong
Hu, Kun
Wu, Qiong
Qiu, Hailong
Xu, Fei
Wang, Mei-Ling
Chen, Xin
Li, Yan
Wang, Ji-Guang https://orcid.org/0000-0001-8511-1524
,
Funding for this research was provided by:
Di’ao Pharmaceuticals
National Natural Science Foundation of China (82370426)
National Natural Science Foundation of China (82270469)
National Natural Science Foundation of China (82070432)
National Natural Science Foundation of China (81970353)
Ministry of Science and Technology, Beijing, China (2022YFC3601302)
Shanghai Municipal Health Commission (202340035)
Shanghai Municipal Health Commission (2022LJ022)
Article History
Received: 31 July 2023
Accepted: 28 December 2023
First Online: 24 January 2024
Declarations
:
: The study protocol was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (2018–45). The patients/participants provided their written informed consent to participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.